Alimera Sciences, Inc 13D/A filing
- 22
Alimera Sciences, Inc 13D/A filing
PR Newswire
CHICAGO, Jan. 27, 2020
CHICAGO, Jan. 27, 2020 /PRNewswire/ -- Private investor, Ronald Chez, increases Alimera position.
Media contact: Elias Matsakis, Holland & Knight LLP
View original content:http://www.prnewswire.com/news-releases/alimera-sciences-inc-13da-filing-300992952.html
SOURCE Ronald L. Chez, Inc.
PR Newswire
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
Lastest news
- GRUPO ELEKTRA ANNOUNCES REVENUE OF Ps.44,562 MILLION AND EBITDA OF Ps.6,363 MILLION IN THE FIRST QUARTER OF 2024
- Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
- Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)
- CORRECTION: Black Hawk Acquisition Corporation Welcomes Mr. Jonathan Ginsberg to Board
- DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord
- Nium and Thredd Expand Partnership to Power B2B Travel Payments in APAC